Aidynbek Zere, Kakenov Erken, Mironova Olga, Ydyrysheva Karlygash, Li Tatyana, Sazonov Vitaliy
Department of Medicine, School of Medicine, Nazarbayev University, Kerey Zhanibek Handar Street 5/1, Astana Z05K4F4, Kazakhstan.
Pediatric Anesthesiology and Intensive Care Unit, Mother and Child Health Center, University Medical Center, Turan 32, Astana Z05G9F0, Kazakhstan.
J Clin Med. 2025 Apr 17;14(8):2771. doi: 10.3390/jcm14082771.
: Tumor lysis syndrome (TLS) is a life-threatening oncologic emergency that occurs in pediatric patients undergoing chemotherapy. Severe complications, including acute respiratory distress syndrome (ARDS), acute kidney injury (AKI), and cardiogenic shock, may require extracorporeal membrane oxygenation (ECMO) support. : This paper is a nonsystematic review of cases that synthesizes available case reports to evaluate the efficacy and outcomes of ECMO in pediatric TLS. : A systematic search identified five cases in which ECMO was used with a mean duration of 14 days. Survival rates were favorable and ECMO played a critical role in bridging these patients through multi-organ failure. : While ECMO is a viable rescue therapy for severe TLS, associated complications, such as infections, bleeding, and neurological impairment, warrant careful patient selection and management. Future studies should explore standardized guidelines for the use of ECMO in pediatric oncology patients.
肿瘤溶解综合征(TLS)是一种危及生命的肿瘤急症,发生于接受化疗的儿科患者。严重并发症,包括急性呼吸窘迫综合征(ARDS)、急性肾损伤(AKI)和心源性休克,可能需要体外膜肺氧合(ECMO)支持。本文是一项非系统性病例综述,综合现有病例报告以评估ECMO在儿科TLS中的疗效和结局。一项系统性检索确定了5例使用ECMO的病例,平均使用时长为14天。生存率良好,且ECMO在帮助这些患者度过多器官功能衰竭方面发挥了关键作用。虽然ECMO是治疗严重TLS的一种可行的挽救疗法,但相关并发症,如感染、出血和神经功能损害,需要谨慎选择患者并进行管理。未来的研究应探索在儿科肿瘤患者中使用ECMO的标准化指南。